Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer
Demographics (2)
- AGE - Subject age at enrollment (phv00543788.v1.p1)
- SEX - Biological sex (phv00543782.v1.p1)
Disease Events (3)
- SAMPLE_AFFECTION_STATUS - Case control status of the sample for esophageal adenocarcinoma (phv00543954.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00543797.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00543796.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00543787.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte type (phv00543791.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00543790.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00543781.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00543793.v1.p1)
- IS_TUMOR - Tumor status (phv00543792.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00543794.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00543795.v1.p1)
- SAMPLE_ID - Sample ID (phv00543789.v1.p1)
- SAMPLE_ID - Sample ID (phv00543784.v1.p1)
- SUBJECT_ID - Subject ID (phv00543785.v1.p1)
- SUBJECT_ID - Subject ID (phv00543780.v1.p1)
- SUBJECT_ID - Subject ID (phv00543783.v1.p1)
- TREATMENT - Type of treatment for subject (phv00543953.v1.p1)